Background: Only limited information is available on the worldwide distribution and volume of adult congenital heart disease (ACHD) centers. We aimed to assess the centers using a bibliometric approach.
Methods And Results: We identified publications presenting original research in the field of ACHD between 1995 and 2011. A total of 94,119 articles were identified which underwent electronic filtering and manual review. Overall, a dramatic increase in ACHD publications was seen over the study period. This was accompanied by a matching increase in impact factors and an over-proportional rise in ACHD contributions relative to the general academic field. Research output correlated well with self-reported patient volume and the number of identified ACHD centers in Europe and North America was in agreement with published surveys, thus validating our methodology. We observed a steady increase in the number of publishing ACHD centers worldwide. The number of ACHD centers per 10-million population was highest for Europe (3.6), followed by North America (1.7), Oceania (1.5), South America (0.4), Asia (0.3) and Africa (0.1). In addition, we evaluated the relative research output between developed and emerging economies and provide an overview over the main areas of research in the ACHD field.
Conclusions: Global interest in ACHD is increasing and this is reflected, both, in the number of publishing centers and the volume of research. Our data provides insights into the geographical and temporal distribution of ACHD research over the last 1 1/2 decades. These results could serve as benchmarks for international comparisons and guide efforts for improving ACHD infrastructure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijcard.2013.07.198 | DOI Listing |
Eur J Clin Invest
December 2024
First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Background: Adults with congenital heart disease (ACHD) can face a lifelong risk of premature cardiovascular events. Endothelial dysfunction and arterial stiffness may be some of the key mechanisms involved. Early identification of endothelial damage in ACHD could be crucial to mitigate the adverse events.
View Article and Find Full Text PDFFront Cardiovasc Med
December 2024
Department of Congenital and Pediatric Cardiac Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany.
Objective: To investigate the long-term impact of cardiac surgery on the quality of life in adults with congenital heart disease (ACHDs).
Methods: Patients who had undergone cardiac surgery for congenital heart disease (CHD) at the age of 18 years or more were recruited in a single-center, cross-sectional study. The enrolled subjects completed online questionnaires to assess patient-reported outcomes: perceived health status and life satisfaction, psychological functioning, health behaviors, and illness perception.
Int J Cardiol Congenit Heart Dis
March 2024
Division of Cardiology, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
Background: Sodium glucose transporter 2 inhibitors (SGLT-2i) have shown safety and efficacy in patients with heart failure (HF). However, evidence for the use of SGLT-2i in adult congenital heart disease (ACHD) patients with HF is limited.
Methods: We performed a retrospective, single center analysis of 18 patients (>18 years of age) with ACHD and a diagnosis of HF who were initiated on an SGLT-2i.
Int J Cardiol Congenit Heart Dis
March 2024
Surgical and Medical Cardiovascular Specialties Direction, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Background: Latin American registries of clinical and demographic profiles of ACHD are scarce. International guidelines classify disease complexity with different approaches. With these two regards, a registry was carried out to examine factors associated with mortality and to compare severity classifications in our population.
View Article and Find Full Text PDFInt J Cardiol Congenit Heart Dis
March 2024
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Introduction: Each year the number of combined heart-liver transplants (HLT) increases, with two distinct patient populations proceeding down this pathway. The first are patients with congenital heart disease (CHD), most commonly single ventricle patients palliated with Fontan. The second group are those with long standing congestive hepatopathy, amyloidosis, hemochromatosis, or alcohol induced myopathies and liver disease.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!